Provider Attitudes and Practices for Alcohol Screening, Treatment, and Education in Patients With Liver Disease: A Survey From the American Association for the Study of Liver Diseases Alcohol-Associated Liver Disease Special Interest Group
Gene Y. Im(Icahn School of Medicine at Mount Sinai), Vijay H. Shah(Mayo Clinic in Arizona), Deepika Devuni(University of Massachusetts Chan Medical School), Loretta Jophlin(University of Louisville), Jessica L. Mellinger(Henry Ford Health System), Aparna Goel(Stanford University), Sandeep Singh Sidhu(Satguru Partap Singh Hospital), Michael R. Lucey(University of California System), Elizabeth S. Aby(University of Minnesota), Adam C. Winters(University of California, Los Angeles), Courtney B. Sherman(University of California, San Francisco), Richard Parker(Leeds Teaching Hospitals NHS Trust), Juan Pablo Arab(Pontificia Universidad Católica de Chile), Ashwani K. Singal(Sanford USD Medical Center), Po‐Hung Chen(Johns Hopkins University), Zurabi Lominadze(University of Maryland, Baltimore), John P. Rice(University of Wisconsin–Madison), Gyöngyi Szabó(Beth Israel Deaconess Medical Center)
Cited by 112
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
The association between hepatitis C infection and survival after orthotopic liver transplantation
|Gastroenterology|2002|1k
Diagnosis and Treatment of Alcohol‐Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases
|Hepatology|2019|869
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789